Stephanie Soucheray, MA Two new studies show immune-compromised patients, including those with cancer and HIV, have varied times until they clear the virus, with some at increased risk for persistent COVID-19 infections. Risks of prolonged infectionIn the first study, published The Lancet Microbe, researchers assessed 150 immunocompromised patients with COVID-19 from five US healthcare systems...
